Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin

Journal of Controlled Release

Volumn 158, Issue 1, 2012, Pages 78-84

  Chen, Xianfeng ^a   Fernando, Germain J P ^a   Raphael, Anthony P ^a   Yukiko, Sally R ^a   Fairmaid, Emily J ^b   Primiero, Clare A ^a   Frazer, Ian H ^a   Brown, Lorena E ^b   Kendall, Mark A F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Microneedles; Microprojections; Needle free vaccination; Skin delivery

Indexed keywords

ANTIBODY RESPONSE; INFLUENZA VACCINES; INTRAMUSCULAR INJECTIONS; LONG LASTING; MICRO-PROJECTION ARRAYS; MICRONEEDLES; MICROPROJECTIONS; MOUSE SKIN; NEEDLE-FREE VACCINATION; SKIN DELIVERY; TIME TO PEAK; TIME WINDOWS;

BODY FLUIDS; KINETICS; NEEDLES; VACCINES;

ANTIBODIES;

ANTIBODY; IMMUNOGLOBULIN G; INFLUENZA VACCINE; NANOPARTICLE;

ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DENSITY; DERMIS; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG TISSUE LEVEL; EAR; EPIDERMIS; FLUORESCENCE; INFLUENZA VACCINATION; INTERMETHOD COMPARISON; KINETICS; MEMBRANE MICROPARTICLE; MOUSE; MUSCLE; NANOFABRICATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIOACTIVITY; TIME TO MAXIMUM PLASMA CONCENTRATION; TISSUE MICROARRAY; VISCOSITY; VOLUMETRY;

ANIMALS; DRUG DELIVERY SYSTEMS; HEMAGGLUTINATION INHIBITION TESTS; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; KINETICS; MICE; MICE, INBRED C57BL; NANOSTRUCTURES; SKIN;

EID: 84857916612     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.10.026     Document Type: Article

References (76)

1. F. Coenen, J. Tolboom, and H.W. Frijlink Stability of influenza sub-unit vaccine-does a couple of days outside the refrigerator matter? Vaccine 24 2006 525 531 (Pubitemid 41832557)
2. J.R. La Montagne, and A.S. Fauci Intradermal influenza vaccination-can less be more? N. Engl. J. Med. 351 2004 2330 2332 (Pubitemid 39552751)
3. W.W. Thompson, D.K. Shay, E. Weintraub, L. Brammer, N. Cox, L.J. Anderson, and K. Fukuda Mortality associated with influenza and respiratory syncytial virus in the United States J. Am. Med. Assoc. 289 2003 179 186 (Pubitemid 36068705)
4. M.T. Osterholm Preparing for the next pandemic N. Engl. J. Med. 352 2005 1839 1842 (Pubitemid 40627807)
5. P.A. Gross, C. Russo, S. Dran, P. Cataruozolo, G. Munk, and S.C. Lancey Time to earliest peak serum antibody response to influenza vaccine in the elderly Clin. Diagn. Lab. Immunol. 4 1997 491 492 (Pubitemid 27321787)
6. P.A. Gross, C. Russo, M. Teplitzky, S. Dran, P. Cataruozolo, and G. Munk Time to peak serum antibody response to influenza vaccine in the elderly Clin. Diagn. Lab. Immunol. 3 1996 361 362 (Pubitemid 26189642)
7. S. Rastogi, P.A. Gross, J. Bonelli, S. Dran, R.A. Levandowski, C. Russo, M.E. Weksler, D. Kaye, M. Levison, E. Abrutyn, D. Murasko, J. Mossey, S. Deichmiller, and R. Hilsen Time to peak serum antibody-response to influenza vaccine Clin. Diagn. Lab. Immunol. 2 1995 120 121
8. D. Hobson, R.L. Curry, A.S. Beare, and A. Wardgard Role of serum hemagglutination-inhibition antibody in protection against challenge against challenge infection with influenza A2 and B viruses J. Hyg. 70 1972 767 777
9. D.L. Noah, H. Hill, D. Hines, E.L. White, and M.C. Wolff Qualification of the Hemagglutination Inhibition Assay in Support of Pandemic Influenza Vaccine Licensure Clin. Vaccine Immunol. 16 2009 558 566
10. P. Eizenberg, R. Booy, N. Naser, G. Mason, D. Stamboulian, and F. Weber Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina Adv. Ther. 28 2011 640 649
11. S.P. Sullivan, D.G. Koutsonanos, M.D. Martin, J.W. Lee, V. Zarnitsyn, S.O. Choi, N. Murthy, R.W. Compans, I. Skountzou, and M.R. Prausnitz Dissolving polymer microneedle patches for influenza vaccination Nat. Med. 16 2010 915 920
12. Y.C. Kim, F.S. Quan, D.G. Yoo, R.W. Compans, S.M. Kang, and M.R. Prausnitz Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles J. Infect. Dis. 201 2010 190 198
13. D.G. Koutsonanos, M.d.P. Martin, V.G. Zarnitsyn, S.P. Sullivan, R.W. Compans, M.R. Prausnitz, and I. Skountzou Transdermal influenza immunization with vaccine-coated microneedle arrays PLoS One 4 2009 e4773
14. F.-S. Quan, Y.-C. Kim, D.-G. Yoo, R.W. Compans, M.R. Prausnitz, and S.-M. Kang Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin PLoS One 4 2009 e7152
15. Y.-C. Kim, F.-S. Quan, R.W. Compans, S.-M. Kang, and M.R. Prausnitz Stability kinetics of influenza vaccine coated onto microneedles during drying and storage Pharm. Res. 28 2011 135 144
16. Q. Zhu, V.G. Zarnitsyn, L. Ye, Z. Wen, Y. Gao, L. Pan, I. Skountzou, H.S. Gill, M.R. Prausnitz, C. Yang, and R.W. Compans Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge Proc. Natl. Acad. Sci. U. S. A. 106 2009 7968 7973
17. M. Pearton, S.M. Kang, J.M. Song, Y.C. Kim, F.S. Quan, A. Anstey, M. Ivory, M.R. Prausnitz, R.W. Compans, and J.C. Birchall Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin Vaccine 28 2010 6104 6113
18. F.S. Quan, Y.C. Kim, A. Vunnava, D.G. Yoo, J.M. Song, M.R. Prausnitz, R.W. Compans, and S.M. Kang Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization J. Virol. 84 2010 7760 7769
19. J.M. Song, Y.C. Kim, A.S. Lipatov, M. Pearton, C.T. Davis, D.G. Yoo, K.M. Park, L.M. Chen, F.S. Quan, J.C. Birchall, R.O. Donis, M.R. Prausnitz, R.W. Compans, and S.M. Kang Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice Clin. Vaccine Immunol. 17 2010 1381 1389
20. Y.L. Chu, and M.R. Prausnitz Separable arrowhead microneedles J. Control. Release 149 2011 242 249
21. Z. Ding, F.J. Verbaan, M. Bivas-Benita, L. Bungener, A. Huckriede, D.J. van den Berg, G. Kersten, and J.A. Bouwstra Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice J. Control. Release 136 2009 71 78
22. Y.C. Kim, F.S. Quan, R.W. Compans, S.M. Kang, and M.R. Prausnitz Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity J. Control. Release 142 2010 187 195
23. G.J.P. Fernando, X. Chen, T.W. Prow, M.L. Crichton, J.F. Emily, M.S. Roberts, I.H. Frazer, L.E. Brown, and M.A.F. Kendall Potent immunity to low doses of influenza vaccine by direct delivery to immune cells in skin PLoS One 5 2010 e10266
24. A.P. Raphael, T.W. Prow, M.L. Crichton, X.F. Chen, G.I.P. Fernando, and M.A.F. Kendall Targeted, needle-free vaccinations in skin using multi layered, densely-packed dissolving microprojection arrays Small 6 2010 1785 1793
25. X. Chen, G.J.P. Fernando, M.L. Crichton, C. Flaim, S.R. Yukiko, E.J. Fairmaid, H.J. Corbett, C.A. Primiero, A.B. Ansaldo, I.H. Frazer, L.E. Brown, and M.A.F. Kendall Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization J. Control. Release 152 2011 349 355
26. J.B. Alarcon, A.W. Hartley, N.G. Harvey, and J.A. Mikszta Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines Clin. Vaccine Immunol. 14 2007 375 381 (Pubitemid 46732547)
27. P. Van Damme, F. Oosterhuis-Kafeja, M. Van der Wielen, Y. Almagor, O. Sharon, and Y. Levin Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults Vaccine 27 2009 454 459
28. F.S. Quan, Y.C. Kim, R.W. Compans, M.R. Prausnitz, and S.M. Kang Dose sparing enabled by skin immunization with influenza virus-like particle using microneedles J. Control. Release 147 2010 326 332
29. H.J. Corbett, G.J. Fernando, X. Chen, I.H. Frazer, and M.A. Kendall Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model PLoS One 5 2010 e13460
30. T.W. Prow, X. Chen, N.A. Prow, G.J.P. Fernando, C.S.E. Tan, A.P. Raphael, D. Chang, M.P. Ruutu, D.W.K. Jenkins, A. Pyke, M.L. Crichton, K. Raphaelli, L.Y.H. Goh, I.H. Frazer, M.S. Roberts, J. Gardner, A.A. Khromykh, A. Suhrbier, R.A. Hall, and M.A.F. Kendall Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya Virus in mice Small 6 2010 1776 1784
31. X. Chen, A.S. Kask, M.L. Crichton, C. McNeilly, S. Yukiko, L. Dong, J.O. Marshak, C. Jarrahian, G.J. Fernando, D. Chen, D.M. Koelle, and M.A. Kendall Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays J. Control. Release 148 2010 327 333
32. C. Nozaki, K. Kaminaka, J. Matsuda, T. Terahara, T. Kuwahara, S. Tolumoto, Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle device, U.S. Patent 2011/0112509, May 12, 2011.
33. X. Chen, T.W. Prow, M.L. Crichton, D.W.K. Jenkins, M.S. Roberts, I.H. Frazer, G.J.P. Fernando, and M.A.F. Kendall Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin J. Control. Release 139 2009 212 220
34. M.L. Crichton, A. Ansaldo, X. Chen, T.W. Prow, G.J.P. Fernando, and M.A.F. Kendall The effect of strain rate on the precision of penetration of short densely-packed microprojection array patches coated with vaccine Biomaterials 31 2010 4562 4572
35. G.J.P. Fernando, D.J. Stenzel, R.W. Tindle, M.S. Merza, B. Morein, and I.H. Frazer Peptide polymerization facilitates incorporation iscoms and increases antigen-specific IgG2a production Vaccine 13 1995 1460 1467
36. S. Fazekas De St Groth, and R.G. Webster Disquisitions on original antigenic sin. I. Evidence in man Exp. Med. 124 1966 331 345
37. N. Charoenthai, P. Kleinebudde, and S. Puttipipatkhachorn Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose AAPS PharmSciTech 8 3 2007 (Article 64)
38. A.T. Florence, and D. Attwood Physicochemical Principles of Pharmacy 4th ed. 2006 Pharmaceutical Press London
39. F. Coenen, J. Tolboom, and H.W. Frijlink Stability of influenza sub-unit vaccine-does a couple of days outside the refrigerator matter? Vaccine 24 2006 525 531 (Pubitemid 41832557)
40. J.R. La Montagne, and A.S. Fauci Intradermal influenza vaccination-can less be more? N. Engl. J. Med. 351 2004 2330 2332 (Pubitemid 39552751)
41. W.W. Thompson, D.K. Shay, E. Weintraub, L. Brammer, N. Cox, L.J. Anderson, and K. Fukuda Mortality associated with influenza and respiratory syncytial virus in the United States J. Am. Med. Assoc. 289 2003 179 186 (Pubitemid 36068705)
42. M.T. Osterholm Preparing for the next pandemic N. Engl. J. Med. 352 2005 1839 1842 (Pubitemid 40627807)
43. P.A. Gross, C. Russo, S. Dran, P. Cataruozolo, G. Munk, and S.C. Lancey Time to earliest peak serum antibody response to influenza vaccine in the elderly Clin. Diagn. Lab. Immunol. 4 1997 491 492 (Pubitemid 27321787)
44. P.A. Gross, C. Russo, M. Teplitzky, S. Dran, P. Cataruozolo, and G. Munk Time to peak serum antibody response to influenza vaccine in the elderly Clin. Diagn. Lab. Immunol. 3 1996 361 362 (Pubitemid 26189642)
45. S. Rastogi, P.A. Gross, J. Bonelli, S. Dran, R.A. Levandowski, C. Russo, M.E. Weksler, D. Kaye, M. Levison, E. Abrutyn, D. Murasko, J. Mossey, S. Deichmiller, and R. Hilsen Time to peak serum antibody-response to influenza vaccine Clin. Diagn. Lab. Immunol. 2 1995 120 121
46. D. Hobson, R.L. Curry, A.S. Beare, and A. Wardgard Role of serum hemagglutination-inhibition antibody in protection against challenge against challenge infection with influenza A2 and B viruses J. Hyg. 70 1972 767 777
47. D.L. Noah, H. Hill, D. Hines, E.L. White, and M.C. Wolff Qualification of the Hemagglutination Inhibition Assay in Support of Pandemic Influenza Vaccine Licensure Clin. Vaccine Immunol. 16 2009 558 566
48. P. Eizenberg, R. Booy, N. Naser, G. Mason, D. Stamboulian, and F. Weber Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina Adv. Ther. 28 2011 640 649
49. S.P. Sullivan, D.G. Koutsonanos, M.D. Martin, J.W. Lee, V. Zarnitsyn, S.O. Choi, N. Murthy, R.W. Compans, I. Skountzou, and M.R. Prausnitz Dissolving polymer microneedle patches for influenza vaccination Nat. Med. 16 2010 915 920
50. Y.C. Kim, F.S. Quan, D.G. Yoo, R.W. Compans, S.M. Kang, and M.R. Prausnitz Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles J. Infect. Dis. 201 2010 190 198
51. D.G. Koutsonanos, M.d.P. Martin, V.G. Zarnitsyn, S.P. Sullivan, R.W. Compans, M.R. Prausnitz, and I. Skountzou Transdermal influenza immunization with vaccine-coated microneedle arrays PLoS One 4 2009 e4773
52. F.-S. Quan, Y.-C. Kim, D.-G. Yoo, R.W. Compans, M.R. Prausnitz, and S.-M. Kang Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin PLoS One 4 2009 e7152
53. Y.-C. Kim, F.-S. Quan, R.W. Compans, S.-M. Kang, and M.R. Prausnitz Stability kinetics of influenza vaccine coated onto microneedles during drying and storage Pharm. Res. 28 2011 135 144
54. Q. Zhu, V.G. Zarnitsyn, L. Ye, Z. Wen, Y. Gao, L. Pan, I. Skountzou, H.S. Gill, M.R. Prausnitz, C. Yang, and R.W. Compans Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge Proc. Natl. Acad. Sci. U. S. A. 106 2009 7968 7973
55. M. Pearton, S.M. Kang, J.M. Song, Y.C. Kim, F.S. Quan, A. Anstey, M. Ivory, M.R. Prausnitz, R.W. Compans, and J.C. Birchall Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin Vaccine 28 2010 6104 6113
56. F.S. Quan, Y.C. Kim, A. Vunnava, D.G. Yoo, J.M. Song, M.R. Prausnitz, R.W. Compans, and S.M. Kang Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization J. Virol. 84 2010 7760 7769
57. J.M. Song, Y.C. Kim, A.S. Lipatov, M. Pearton, C.T. Davis, D.G. Yoo, K.M. Park, L.M. Chen, F.S. Quan, J.C. Birchall, R.O. Donis, M.R. Prausnitz, R.W. Compans, and S.M. Kang Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice Clin. Vaccine Immunol. 17 2010 1381 1389
58. Y.L. Chu, and M.R. Prausnitz Separable arrowhead microneedles J. Control. Release 149 2011 242 249
59. Z. Ding, F.J. Verbaan, M. Bivas-Benita, L. Bungener, A. Huckriede, D.J. van den Berg, G. Kersten, and J.A. Bouwstra Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice J. Control. Release 136 2009 71 78
60. Y.C. Kim, F.S. Quan, R.W. Compans, S.M. Kang, and M.R. Prausnitz Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity J. Control. Release 142 2010 187 195
61. G.J.P. Fernando, X. Chen, T.W. Prow, M.L. Crichton, J.F. Emily, M.S. Roberts, I.H. Frazer, L.E. Brown, and M.A.F. Kendall Potent immunity to low doses of influenza vaccine by direct delivery to immune cells in skin PLoS One 5 2010 e10266
62. A.P. Raphael, T.W. Prow, M.L. Crichton, X.F. Chen, G.I.P. Fernando, and M.A.F. Kendall Targeted, needle-free vaccinations in skin using multi layered, densely-packed dissolving microprojection arrays Small 6 2010 1785 1793
63. X. Chen, G.J.P. Fernando, M.L. Crichton, C. Flaim, S.R. Yukiko, E.J. Fairmaid, H.J. Corbett, C.A. Primiero, A.B. Ansaldo, I.H. Frazer, L.E. Brown, and M.A.F. Kendall Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization J. Control. Release 152 2011 349 355
64. J.B. Alarcon, A.W. Hartley, N.G. Harvey, and J.A. Mikszta Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines Clin. Vaccine Immunol. 14 2007 375 381 (Pubitemid 46732547)
65. P. Van Damme, F. Oosterhuis-Kafeja, M. Van der Wielen, Y. Almagor, O. Sharon, and Y. Levin Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults Vaccine 27 2009 454 459
66. F.S. Quan, Y.C. Kim, R.W. Compans, M.R. Prausnitz, and S.M. Kang Dose sparing enabled by skin immunization with influenza virus-like particle using microneedles J. Control. Release 147 2010 326 332
67. H.J. Corbett, G.J. Fernando, X. Chen, I.H. Frazer, and M.A. Kendall Skin vaccination against cervical cancer associated human papillomavirus with a novel micro-projection array in a mouse model PLoS One 5 2010 e13460
68. T.W. Prow, X. Chen, N.A. Prow, G.J.P. Fernando, C.S.E. Tan, A.P. Raphael, D. Chang, M.P. Ruutu, D.W.K. Jenkins, A. Pyke, M.L. Crichton, K. Raphaelli, L.Y.H. Goh, I.H. Frazer, M.S. Roberts, J. Gardner, A.A. Khromykh, A. Suhrbier, R.A. Hall, and M.A.F. Kendall Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya Virus in mice Small 6 2010 1776 1784
69. X. Chen, A.S. Kask, M.L. Crichton, C. McNeilly, S. Yukiko, L. Dong, J.O. Marshak, C. Jarrahian, G.J. Fernando, D. Chen, D.M. Koelle, and M.A. Kendall Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays J. Control. Release 148 2010 327 333
70. C. Nozaki, K. Kaminaka, J. Matsuda, T. Terahara, T. Kuwahara, S. Tolumoto, Microneedle device, and method for enhancing the efficacy of influenza vaccine by using microneedle device, U.S. Patent 2011/0112509, May 12, 2011.
71. X. Chen, T.W. Prow, M.L. Crichton, D.W.K. Jenkins, M.S. Roberts, I.H. Frazer, G.J.P. Fernando, and M.A.F. Kendall Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin J. Control. Release 139 2009 212 220
72. M.L. Crichton, A. Ansaldo, X. Chen, T.W. Prow, G.J.P. Fernando, and M.A.F. Kendall The effect of strain rate on the precision of penetration of short densely-packed microprojection array patches coated with vaccine Biomaterials 31 2010 4562 4572
73. G.J.P. Fernando, D.J. Stenzel, R.W. Tindle, M.S. Merza, B. Morein, and I.H. Frazer Peptide polymerization facilitates incorporation iscoms and increases antigen-specific IgG2a production Vaccine 13 1995 1460 1467
74. S. Fazekas De St Groth, and R.G. Webster Disquisitions on original antigenic sin. I. Evidence in man Exp. Med. 124 1966 331 345
75. N. Charoenthai, P. Kleinebudde, and S. Puttipipatkhachorn Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose AAPS PharmSciTech 8 3 2007 (Article 64)
76. A.T. Florence, and D. Attwood Physicochemical Principles of Pharmacy 4th ed. 2006 Pharmaceutical Press London